Circulating levels of interleukin (IL)-12 and IL-13 in Helicobacter pylori-infected patients, and their associations with bacterial CagA and VacA virulence factors

References

• Varbanova M, Malfertheiner P. Bacterial load and degree of gastric mucosal inflammation in Helicobacter pylori infection. Dig Dis 2011;29:592–9.
   PubMedGoogle Scholar
• D’Elios MM, Andersen LP. Inflammation, immunity, and vaccines for Helicobacter pylori. Helicobacter 2009;14:21–8.
   PubMedGoogle Scholar
• Massarrat S, Saberi-Firoozi M, Soleimani A, Himmelmann GW, Hitzges M, Keshavarz H. Peptic ulcer disease, irritable bowel syndrome and constipation in two populations in Iran. Eur J Gastroenterol Hepatol 1995;7:427–33.
   PubMed Web of Science ®Google Scholar
• Siavoshi F, Malekzadeh R, Daneshmand M, Ashktorab H. Helicobacter pylori endemic and gastric disease. Dig Dis Sci 2005;50:2075–80.
   PubMedGoogle Scholar
• Terradot L, Waksman G. Architecture of the Helicobacter pylori Cag-type IV secretion system. FEBS J 2011;278:1213–22.
   PubMed Web of Science ®Google Scholar
• Molnar B, Galamb O, Sipos F, Leiszter K, Tulassay Z. Molecular pathogenesis of Helicobacter pylori infection: the role of bacterial virulence factors. Dig Dis 2010;28:604–8.
   PubMed Web of Science ®Google Scholar
• Ozen A, Ertem D, Pehlivanoglu E. Natural history and symptomatology of Helicobacter pylori in childhood and factors determining the epidemiology of infection. J Pediatr Gastroenterol Nutr 2006;42:398–404.
   PubMed Web of Science ®Google Scholar
• Mitchell HM, Hazell SL, Li YY, Hu PJ. Serological response to specific Helicobacter pylori antigens: antibody against CagA antigen is not predictive of gastric cancer in a developing country. Am J Gastroenterol 1996;91:1785–8.
   PubMed Web of Science ®Google Scholar
• Jafarzadeh A, Rezayati MT, Nemati M. Specific serum immunoglobulin G to H. pylori and CagA in healthy children and adults (south-east of Iran). World J Gastroenterol 2007; 13:3117–21.
   PubMedGoogle Scholar
• D’Elios MM, Montecucco C, de Bernard M. VacA and HP-NAP, Ying and Yang of Helicobacter pylori-associated gastric inflammation. Clin Chim Acta 2007;381:32–8.
   PubMedGoogle Scholar
• Shirasaka D, Aoyama N, Satonaka K, Shirakawa K, Yoshida H, Sakai T, et al. Analysis of Helicobacter pylori vacAgene and serum antibodies to VacA in Japan. Dig Dis Sci 2000;45:789–95.
   PubMedGoogle Scholar
• Yamaoka Y. Mechanisms of disease: Helicobacter pylori virulence factors. Nat Rev Gastroenterol Hepatol 2010;7:629–41.
   PubMed Web of Science ®Google Scholar
• Wen S, Moss SF. Helicobacter pylori virulence factors in gastric carcinogenesis. Cancer Lett 2009;282:1–8.
   PubMed Web of Science ®Google Scholar
• Queiroz DM, Cunha RP, Saraiva IE, Rocha AM. Helicobacter pylori virulence factors as tools to study human migrations. Toxicon 2010;56:1193–7.
   PubMedGoogle Scholar
• Bauditz J, Ortner M, Bierbaum M, Niedobitek G, Lochs H, Schreiber S. Production of IL-12 in gastritis relates to infection with Helicobacter pylori. Clin Exp Immunol 1999;117:316–23.
   PubMed Web of Science ®Google Scholar
• Garrote JA, Gomez-Gonzalez E, Bernardo D, Arranz E, Chirdo F. Celiac disease pathogenesis: the proinflammatory cytokine network. J Pediatr Gastroenterol Nutr 2008;47: S27–32.
   PubMed Web of Science ®Google Scholar
• de Bernard M, D’Elios MM. The immune modulating activity of the Helicobacter pylori HP-NAP: friend or foe?Toxicon 2010;56:1186–92.
   PubMedGoogle Scholar
• Dinarello CA. Interleukin-18 and the pathogenesis of inflammatory diseases. Semin Nephrol 2007;27:98–114.
   PubMed Web of Science ®Google Scholar
• D’Elios MM, Amedei A, Cappon A, Del Prete G, de Bernard M. The neutrophil-activating protein of Helicobacter pylori (HP-NAP) as an immune modulating agent. FEMS Immunol Med Microbiol 2007;50:157–64.
   PubMed Web of Science ®Google Scholar
• Peluso I, Pallone F, Monteleone G. Interleukin-12 and Th1 immune response in Crohn's disease: pathogenetic relevance and therapeutic implication. World J Gastroenterol 2006;12:5606–10.
   PubMed Web of Science ®Google Scholar
• Pellicano A, Sebkova L, Monteleone G, Guarnieri G, Imeneo M, Pallone F, et al. Interleukin-12 drives the Th1 signaling pathway in Helicobacter pylori-infected human gastric mucosa. Infect Immun 2007;75:1738–44.
   PubMed Web of Science ®Google Scholar
• Takeshima E, Tomimori K, Teruya H, Ishikawa C, Senba M, D’Ambrosio D, et al. Helicobacter pylori-induced interleukin-12 p40 expression. Infect Immun 2009;77:1337–48.
   PubMedGoogle Scholar
• D’Elios MM, Amedei A, Benagiano M, Azzurri A, Del Prete G. Helicobacter pylori, T cells and cytokines: the “dangerous liaisons”. FEMS Immunol Med Microbiol 2005;44:113–9.
   PubMedGoogle Scholar
• Romero-Adrian TB, Leal-Montiel J, Monsalve-Castillo F, Mengual-Moreno E, McGregor EG, Perini L, et al. Helicobacter pylori: bacterial factors and the role of cytokines in the immune response. Curr Microbiol 2010;60:143–55.
   PubMedGoogle Scholar
• Fuss IJ, Strober W. The role of IL-13 and NK T cells in experimental and human ulcerative colitis. Mucosal Immunol 2008;1:S31–3.
   PubMed Web of Science ®Google Scholar
• Wills-Karp M, Finkelman FD. Untangling the complex web of IL-4- and IL-13-mediated signaling pathways. Sci Signal 2008;1:pe55.
   Google Scholar
• Luzza F, Parrello T, Sebkova L, Pensabene L, Imeneo M, Mancuso M, et al. Expression of proinflammatory and Th1 but not Th2 cytokines is enhanced in gastric mucosa of Helicobacter pylori infected children. Dig Liver Dis 2001; 33:14–20.
   PubMedGoogle Scholar
• Kayhan B, Arasli M, Eren H, Aydemir S, Aktas E, Tekin I. Analysis of peripheral blood lymphocyte phenotypes and Th1/Th2 cytokines profile in the systemic immune responses of Helicobacter pylori infected individuals. Microbiol Immunol 2008;52:531–8.
   PubMedGoogle Scholar
• Rauws EA, Tytgat GN. Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet 1990;335: 1233–5.
   PubMed Web of Science ®Google Scholar
• Suriani R, Colozza M, Cardesi E, Mazzucco D, Marino M, Grosso S, et al. CagA and VacA Helicobacter pylori antibodies in gastric cancer. Can J Gastroenterol 2008;22:255–8.
   Google Scholar
• Parrello T, Monteleone G, Cucchiara S, Monteleone I, Sebkova L, Doldo P, et al. Up-regulation of the IL-12 receptor beta 2 chain in Crohn's disease. J Immunol 2000;165: 7234–9.
   PubMed Web of Science ®Google Scholar
• Mannon PJ, Fuss IJ, Dill S, Friend J, Groden C, Hornung R, et al. Excess IL-12 but not IL-23 accompanies the inflammatory bowel disease associated with common variable immunodeficiency. Gastroenterology 2006;131:748–56.
   PubMed Web of Science ®Google Scholar
• Ebrahimi AA, Noshad H, Sadreddini S, Hejazi MS, Mohammadzadeh Sadigh Y, Eshraghi Y, et al. Serum levels of TNF-alpha, TNF-alphaRI, TNF-alphaRII and IL-12 in treated rheumatoid arthritis patients. Iran J Immunol 2009;6:147–53.
   PubMedGoogle Scholar
• Lauwerys BR, Van Snick J, Houssiau FA. Serum IL-12 in systemic lupus erythematosus: absence of p70 heterodimers but presence of p40 monomers correlating with disease activity. Lupus 2002;11:384–7.
   PubMed Web of Science ®Google Scholar
• Wong CK, Ho CY, Li EK, Lam CW. Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus. Lupus 2000;9:589–93.
   PubMed Web of Science ®Google Scholar
• Musabak U, Demirkaya S, Genc G, Ilikci RS, Odabasi Z. Serum adiponectin, TNF-alpha, IL-12p70, and IL-13 levels in multiple sclerosis and the effects of different therapy regimens. Neuroimmunomodulation 2011;18:57–66.
   PubMedGoogle Scholar
• Tazaki T, Minoguchi K, Yokoe T, Oda N, Hashimoto T, Tanaka A, et al. Allergen rush immunotherapy increases interleukin (IL)-12 production and IL-12 receptor beta2 chain expression in patients with allergic asthma. Cell Immunol 2004;228:20–6.
   PubMed Web of Science ®Google Scholar
• Andres S, Schmidt HM, Mitchell H, Rhen M, Maeurer M, Engstrand L. Helicobacter pylori defines local immune response through interaction with dendritic cells. FEMS Immunol Med Microbiol 2011;61:168–78.
   PubMedGoogle Scholar
• Shi Y, Liu XF, Zhuang Y, Zhang JY, Liu T, Yin Z, et al. Helicobacter pylori-induced Th17 responses modulate Th1 cell responses, benefit bacterial growth, and contribute to pathology in mice. J Immunol 2010;184:5121–9.
   PubMed Web of Science ®Google Scholar
• Otani K, Watanabe T, Tanigawa T, Okazaki H, Yamagami H, Watanabe K, et al. Anti-inflammatory effects of IL-17A on Helicobacter pylori-induced gastritis. Biochem Biophys Res Commun 2009;382:252–8.
   PubMed Web of Science ®Google Scholar
• Garcia-Gonzalez MA, Lanas A, Wu J, Benito R, Santolaria S, Crusius B, et al. Lack of association of IL-12 p40 gene polymorphism with peptic ulcer disease. Hum Immunol 2005;66:72–6.
   PubMed Web of Science ®Google Scholar
• Sakai K, Kita M, Sawai N, Shiomi S, Sumida Y, Kanemasa K, et al. Levels of interleukin-18 are markedly increased in Helicobacter pylori-infected gastric mucosa among patients with specific IL18 genotypes. J Infect Dis 2008;197:1752–61.
   PubMedGoogle Scholar
• Deml L, Aigner M, Decker J, Eckhardt A, Schutz C, Mittl PR, et al. Characterization of the Helicobacter pylori cysteine-rich protein A as a T-helper cell type 1 polarizing agent. Infect Immun 2005;73:4732–42.
   PubMedGoogle Scholar
• Obonyo M, Cole SP, Datta SK, Guiney DG. Evidence for interleukin-1-independent stimulation of interleukin-12 and down-regulation by interleukin-10 in Helicobacter pylori-infected murine dendritic cells deficient in the interleukin-1 receptor. FEMS Immunol Med Microbiol 2006;47:414–9.
   PubMed Web of Science ®Google Scholar
• Hida N, Shimoyama T Jr, Neville P, Dixon MF, Axon AT, Shimoyama T Sr, et al. Increased expression of IL-10 and IL-12 (p40) mRNA in Helicobacter pylori infected gastric mucosa: relation to bacterial cag status and peptic ulceration. J Clin Pathol 1999;52:658–64.
   PubMed Web of Science ®Google Scholar
• Augusto AC, Miguel F, Mendonca S, Pedrazzoli J Jr, Gurgueira SA. Oxidative stress expression status associated to Helicobacter pylori virulence in gastric diseases. Clin Biochem 2007;40:615–22.
   PubMed Web of Science ®Google Scholar
• de Jonge R, Kusters JG, Timmer MS, Gimmel V, Appelmelk BJ, Bereswill S, et al. The role of Helicobacter pylori virulence factors in interleukin production by monocytic cells. FEMS Microbiol Lett 2001;196:235–8.
   PubMedGoogle Scholar
• Yokota K, Kobayashi K, Kawahara Y, Hayashi S, Hirai Y, Mizuno M, et al. Gastric ulcers in SCID mice induced by Helicobacter pylori infection after transplanting lymphocytes from patients with gastric lymphoma. Gastroenterology 1999;117:893–9.
   PubMedGoogle Scholar
• Thomson AB, Appleman S, Keelan M, Wallace JL. Role of gastric mucosal and gastric juice cytokine concentrations in development of bisphosphonate damage to gastric mucosa. Dig Dis Sci 2003;48:308–14.
   PubMed Web of Science ®Google Scholar
• Lemke LB, Ge Z, Whary MT, Feng Y, Rogers AB, Muthupalani S, et al. Concurrent Helicobacter bilis infection in C57BL/6 mice attenuates proinflammatory H. pylori- induced gastric pathology. Infect Immun 2009;77:2147–58.
   PubMedGoogle Scholar
• Marotti B, Rocco A, De Colibus P, Compare D, de Nucci G, Staibano S, et al. Interleukin-13 mucosal production in Helicobacter pylori-related gastric diseases. Dig Liver Dis 2008;40:240–7.
   PubMedGoogle Scholar